The cough syrup claimed 65 lives of children lives in Uzbekistan.


Tashkent: Startling revelations have emerged during the investigation against an Indian pharmaceutical company, as suspicions of profiting from substandard cough syrup led to the use of insecticide components, resulting in the deaths of 65 children in Uzbekistan.
According to details, the CEO of the Indian-origin Caramex Pharmaceuticals, Mr. Singh, had signed a deal with his own country's company, Mirion BioTech, to produce low-quality cough syrup.
Driven by the desire for greater gains, the company surreptitiously introduced insecticide components into the syrup.
Chief Operating Officer, Mr. Tar Singh, admitted to bribery and revealed that he had bribed Uzbek authorities with $33,000 to overlook quality tests.
Uzbek authorities reported that Caramex manipulated the syrup's price for tax evasion as well.
It is worth noting that in December 2022, 65 children in Uzbekistan died due to the use of cough syrup, raising suspicions.
Following the scandal's exposure, several countries including the United States and the European Union suspended the license of the Indian company Mirion BioTech.

OpenAI unveils free lite version of deep research tool
- 11 hours ago

CMC: 'Zero restrictions' after injury-marred '24
- 11 hours ago

54 terrorists killed as Pakistan foils border infiltration attempt
- 10 hours ago

4.4 magnitude earthquake jolts Swat and nearby areas
- 12 hours ago

Karachi fire forces gas shutdown, repairs expected in 4 hours
- 12 hours ago

Saudi delegation in Pakistan to review Hajj travel arrangements
- 8 hours ago
Sikhs will not allow Indian Army to cross Punjab: Gharpatan Singh Pannu
- 12 hours ago

Notre Dame's Carr, Minchey to vie for top QB
- 11 hours ago
New era for Crypto in Pakistan as govt signs historic agreement
- 9 hours ago

'Incredible' Tkachuk returns, nets 2 for Panthers
- 11 hours ago
Extremist Indians attack Pakistan High Commission in London
- 12 hours ago
Sajal Malik opens up about family ties to Imran Ashraf
- 11 hours ago